NovoCure (NVCR) Launches 12.5M Common Stock IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- S&P 500 ends higher as investors await tech earnings
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 2, 2015 6:00 AM EDTADVISORY, Oct. 02, 2015 (GLOBE NEWSWIRE) --
What:Â
NovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive Officer and Bill Doyle, Executive Chairman will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Friday, October 2, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â
NovoCure... More
NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 2, 2015 6:00 AM EDTADVISORY, Oct. 02, 2015 (GLOBE NEWSWIRE) --
What:Â
NovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive Officer and Bill Doyle, Executive Chairman will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Friday, October 2, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â
NovoCure... More
NovoCure Limited Announces Launch of Initial Public Offering
October 1, 2015 9:07 PM EDTST. HELIER, Jersey--(BUSINESS WIRE)-- NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common stock, including 7,500,000 shares to be sold by NovoCure Limited and 5,000,000 shares to be sold by selling shareholders. The initial public offer is currently expected to be between $26 and $29 per share. The underwriters for the offering will also have a 30-day option to purchase up to an additional 1,875,000 ordinary shares from the selling shareholders. NovoCure Limited has applied to list its common stock on the NASDAQ... More
